Tech Center 1600 • Art Units: 1621 1629 1684
This examiner grants 58% of resolved cases
Nicola Maria Bauer examines applications in Art Unit 1621 within Tech Center 1600. She has reached a final resolution in 60 cases, providing a focused data set for evaluating her prosecution style. The allowance rate pct of 58.3 indicates a moderate success rate, where more than half of the applications result in a patent grant. This 58.3 percent rate suggests that while success is achievable, applicants must be diligent in addressing examiner concerns. The median days to allowance is 1378, reflecting an exceptionally long prosecution timeline for successful cases. This 1378-day median indicates that practitioners should prepare for an extended period of examination in Tech Center 1600.
A critical insight from the data is the interview lift pct of 50.0. This high lift suggests that conducting an interview significantly improves the probability of allowance compared to cases without such interaction. By engaging in verbal negotiation, applicants can potentially overcome the hurdles that lead to the 58.3 percent baseline rate. Given the 1378-day median wait, an early interview may be a vital tactic for clarifying issues and moving the application toward a grant. The 60 resolved cases show that direct communication is a highly effective tool in Art Unit 1621. Practitioners should prioritize interviews as a primary method for navigating the lengthy and challenging prosecution environment associated with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18257167 | CB2 RECEPTOR AGONISTS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18557899 | STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOF | Non-Final OA | ALCON INC. |
| 18524612 | PREPARATION OF FUSED AZOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE 0-ACYLTRANSFERASE 2 INHIBITORS | Non-Final OA | Merck Sharp & Dohme LLC |
| 18041475 | METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18063048 | BINDING SITE IN TYPE 2 RYANODINE RECEPTOR | Non-Final OA | The Trustees of Columbia University in the City of New York |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy